观察值与预期值比值作为喉癌治疗指南依从性的医疗质量指标
该回顾性分析利用SEER-Medicare数据评估2004至2007年确诊的喉癌患者,计算各医院对国家综合癌症网络(NCCN)指南依从性的观察值与预期值(O/E)比值。1,721例患者中43.0%接受了指南依从性治疗;O/E≥1的医院相比O/E<1的医院及低容量医院,患者生存改善(HR=0.83,95%CI 0.70-0.98)且平均增量治疗费用更低(-$3,009,95%CI -$5,226至-$791)。
要点
- 43.0%的喉癌患者接受了NCCN指南依从性治疗。
- O/E≥1医院患者生存改善(HR=0.83,95%CI 0.70-0.98)。
- O/E≥1医院平均增量治疗费用降低-$3,009(95%CI -$5,226至-$791)。
核心结论
- 医院特异性NCCN治疗指南依从性O/E比值结合最低病例量标准与老年喉癌患者的生存和治疗相关费用相关,可能是一种可行的喉癌医疗质量指标。
研究设计与样本
- 回顾性分析监测、流行病学和最终结果(SEER)-Medicare数据,纳入2004至2007年确诊的喉癌患者,使用多因素回归和生存分析。
- 基于NCCN指南推荐治疗的质量指标,拟合逻辑回归模型计算每家医院的指南依从性O/E比值,并按医院容量分层。
主要发现
- 在395家医院治疗的1,721例患者中,43.0%接受了NCCN指南依从性治疗。
- 低容量医院(N=295,治疗6例或以下)治疗765例患者(44.5%),平均O/E为0.96±0.45。
- 治疗超过6例且O/E<1的医院(N=32)治疗284例患者(16.5%),平均O/E为0.77±0.18。
- 治疗超过6例且O/E≥1的医院(N=68)治疗672例患者(39.1%),平均O/E为1.17±0.11。
- 与O/E<1医院(HR=1.00,95%CI 0.80-1.24)及低容量医院参照组相比,O/E≥1医院治疗与生存改善(HR=0.83,95%CI 0.70-0.98)和较低的平均增量治疗相关费用(-$3,009,95%CI -$5,226至-$791)相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To examine associations between survival and adherence to National Comprehensive Cancer Network (NCCN) treatment guidelines using an observed-to-expected (O/E) ratio for greater adherence as a risk-adjusted hospital measure of quality care in elderly patients treated for larynx cancer. STUDY DESIGN: Retrospective analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare data. METHODS: Patients diagnosed with larynx cancer from 2004 to 2007 were evaluated using multivariate regression and survival analysis. A fit logistic regression model was used to calculate an O/E ratio for guideline adherence for each hospital using quality indicators derived from NCCN guidelines for recommended treatment and stratified by hospital volume. RESULTS: Of 1,721 patients treated at 395 hospitals, 43.0% of patients received NCCN guideline-adherent care. Low-volume hospitals (N = 295) treating six or fewer cases treated 765 patients (44.5%), with a mean O/E of 0.96 ± 0.45. Hospitals treating more then six cases with an O/E <1 (N = 32) treated 284 patients (16.5%), with a mean O/E of 0.77 ± 0.18. Hospitals treating more than six cases with an O/E ≥1 (N = 68) treated 672 patients (39.1%), with a mean O/E of 1.17 ± 0.11. Treatment at hospitals with an O/E ≥1 was associated with improved survival (hazard ratio [HR] = 0.83 [95% confidence interval [CI]: 0.70 to 0.98]) and lower mean incremental treatment-related costs (-$3,009 [-$5,226 to -$791]) compared with hospitals with an O/E <1 (HR = 1.00 [0.80 to 1.24]) and the reference group of low-volume hospitals. CONCLUSIONS: A hospital-specific O/E for NCCN treatment guideline adherence, combined with a minimum case volume criterion, is associated with survival and treatment-related costs in elderly patients with larynx cancer, and may be a feasible measure of larynx cancer quality of care. LEVEL OF EVIDENCE: NA Laryngoscope, 130:672-678, 2020.
引用
- Swegal WC, Herbert RJ, Eisele DW, et al. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer. Laryngoscope. 2019. PMID: 31169916. doi:10.1002/lary.28104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。